Examining the Clinicodermoscopic and Histopathological Progression of Acquired Reactive Perforating Collagenosis: A Case Study
By
Jue Wang
Lizhu Chen
Xinlong Chen
Nuoyan Li
Mingling Chen
Zhifei Wen
June 16, 2026
Clinical Scorecard: Examining the Clinicodermoscopic and Histopathological Progression of Acquired Reactive Perforating Collagenosis: A Case Study
At a Glance
Category Detail
Condition Key Mechanisms Transepidermal elimination of altered dermal collagen Target Population Patients with systemic metabolic disorders, particularly diabetes mellitus Care Setting
Key Highlights
ARPC often misdiagnosed before overt transepidermal elimination occurs Early lesions show distinct dermoscopic features compared to fully developed lesions Histopathological examination reveals abnormal collagen aggregation in early lesions Dermoscopy aids in biopsy-site selection for accurate diagnosis Guideline-Based Recommendations
Diagnosis
Utilize dermoscopy for early identification of ARPC features Consider targeted biopsy of early lesions for histopathological confirmation Management
Recognize early signs of ARPC Monitoring & Follow-up
Regular follow-up for patients with systemic metabolic disorders to identify skin changes Risks
Misdiagnosis can lead to inappropriate treatment and delayed management Patient & Prescribing Data
Individuals with a history of metabolic disorders, particularly diabetes mellitus
Clinical Best Practices
Correlate dermoscopic findings with histopathological changes Related Resources & Content
